AML-GMP expressed granulocyte–monocyte progenitor markers such as Mpo, Elane, Prss57 and Ctsg22,26,33, along with Gstm1, which has been associated with quiescent, therapy-resistant, leukemia-initiating cells in AML35–37. This evidence concerns the gene MPO and leukemia.